Comparative effectiveness research
may also play a future role in health care payment policy in the United States.
Development of the research infrastructure to efficiently conduct comparative effectiveness research
is one important strategy to address the barriers to generating better evidence of clinical utility.
Journal (Weinstein 2010) and the Washington Post (Brown 2012) used the COURAGE trial to illustrate the challenges facing policy makers who want to rein in costs using comparative effectiveness research
. However, there has been little research on the impact of the COURAGE trial on practice patterns.
Mullins et al., "Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research
in adult oncology," Journal of Clinical Oncology, vol.
* Armando Franco, University of California, Berkeley; Dana Goldman, University of Southern California and NBER; Adam Leive, University of Pennsylvania; and Daniel McFadden, University of California, Berkeley and NBER, "A Cautionary Tale in Comparative Effectiveness Research
: Pitfalls and Perils of Observational Data Analysis"
The pharmaceutical and durable medical equipment industries are also likely to mount criticism as they experience the financial repercussions of comparative effectiveness research
sponsored by PCORI.
Tilford, who has taught in the department since 2010, also serves as co-director of the comparative effectiveness research
component of the UAMS Translational Research Institute.
The Federal Agency for Healthcare Research and Quality (AHRQ) recently launched efforts to promote comparative effectiveness research
(CER), a type of patient-centered outcomes research, in patient and professional communities in all 50 states, Washington, D.C., and the U.S.
AzNA is partnering with AHRQ to raise awareness and encourage use of comparative effectiveness research
, a type of patient-centered outcomes research.
As currently organized, comparative effectiveness research
will be used to increase government control over the practice of medicine and is a slippery slope towards the introduction of price controls.
Specific topics include: research and development contract terms in the bio/pharmaceutical sector; effects of regulation on drug launch and pricing in interdependent markets; the effect of pharmaceutical innovation on the functional limitations of elderly Americans; comparative effectiveness research
, technological abandonment, and health care spending; the influence of initial signals of quality on the diffusion of new cancer drug treatments; technology diffusion and substitution of medical innovations; and health insurance and hospital technology adoption.